ASLM

News ArticlesStories from the Fleming Fund Programme

Stories from the Fleming Fund Programme

Stories from the Fleming Fund Programme

LabVoice Issue 02

Dr. Ranyl Nguena – Cameroon (Fellow)

Through my work with ASLM, I contributed to the development of 10 national strategic documents in Cameroon, including the national AMR action plan, integrated and genomic surveillance guidelines, and training materials for the animal health sector. These experiences opened opportunities for me to serve as an evaluator with FAO and WHO, where I assessed laboratories, surveillance systems, and national action plans across multiple African countries. I also led a continent-wide synthesis of FAO AMR evaluations conducted since 2018, compiling and analysing data from more than 220 laboratories and 27 surveillance systems. Beyond policy documents, the programme enabled me to support AMR mapping in Cameroon, contribute to regional training platforms, and help train new cohorts of professionals in AMR data analysis and epidemiology.”

Dr. Christopher Sikombe – Tanzania

Acting Assistant Director for Vector and Parasitic Disease Control, Ministry of Livestock and Fisheries

“As an animal health Fleming Fund Fellow, I was equipped in the handling of surveillance data. We now have a clear surveillance framework with defined roles, SOPs for data collection and diagnosis, and are submitting our data internationally. The Fleming Fund broke down silos—animal, human, and environmental health sectors now collaborate under a One Health approach. With improved digital reporting and analytical capacity, we are shaping evidence-based policy and prioritising antimicrobial stewardship in animal health.”

Dr. Godwin Minga – Tanzania

Central Veterinary Laboratory

“The QWARS microbiology track provided a strong foundation in laboratory diagnostics and quality, enabling us to generate reliable AMR data for national treatment guidelines. Through the fellowship, I expanded into antimicrobial use and consumption, contributing data that feeds into One Health decision-making. Improved collaboration with human health partners led to the decision to phase out the use of a critical antibiotic in animals. I remain committed to strengthening veterinary laboratories and advocating for continued investment in the AMR workforce.”